Previous Close | 401.98 |
1-Year Change | -18.02% |
6-Months Change | -23.24% |
3-Months Change | -6.28% |
Moving Avg (50d) | 388.5 |
Moving Avg (200d) | 481.55 |
ESG Rating | - |
Exchange | NYSE |
Market Cap. | 94.4B |
Beta (3-Years) | 0.5 |
Revenue Growth (ttm) | 10.03% |
Net Profit Margin (ttm) | 3.56% |
Return On Assets (ttm) | 5.43% |
EPS (ttm) | 25.15 |
PE Ratio (ttm) | 15.98 |
Dividend Yield | 1.42% |
Asset Description: | Elevance Health Inc. |
Predicted Direction: | Sell |
Signal Strength: | Strong sell |
Forecast Date: | 2024-12-17 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
410.02 | 422.079 | 430.119 | 442.178 | 462.277 | 482.376 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.